These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8194842)

  • 1. Oligonucleotides in the treatment of leukemia.
    Bayever E; Iversen P
    Hematol Oncol; 1994; 12(1):9-14. PubMed ID: 8194842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense strategy in hematological malignancies.
    Warzocha K
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):15-23. PubMed ID: 10390076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First antisense drug trials planned in leukemia.
    Reynolds T
    J Natl Cancer Inst; 1992 Mar; 84(5):288-90. PubMed ID: 1738177
    [No Abstract]   [Full Text] [Related]  

  • 4. Antisense gene therapy trials underway in patients with CML.
    Oncology (Williston Park); 1996 Sep; 10(9):1411. PubMed ID: 8882929
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in molecular biology of leukemias--clinical implications].
    Skórski T
    Acta Haematol Pol; 1995; 26(2 Suppl 1):14-8. PubMed ID: 7653230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise?
    de Fabritiis P; Calabretta B
    Haematologica; 1995; 80(4):295-9. PubMed ID: 7590496
    [No Abstract]   [Full Text] [Related]  

  • 7. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
    Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotide therapeutics for human leukemia.
    Gewirtz AM
    Crit Rev Oncog; 1997; 8(1):93-109. PubMed ID: 9516088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense strategies in the treatment of leukemias.
    Calabretta B; Skorski T; Ratajczak MZ; Gewirtz AM
    Semin Oncol; 1996 Feb; 23(1):78-87. PubMed ID: 8607034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing oligonucleotide therapeutics for human leukemia.
    Gewirtz AM
    Anticancer Drug Des; 1997 Jul; 12(5):341-58. PubMed ID: 9236851
    [No Abstract]   [Full Text] [Related]  

  • 11. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for gene-directed therapy with antisense oligodeoxynucleotides.
    Calabretta B; Skorski T; Szczylik C; Zon G
    Cancer Treat Rev; 1993 Apr; 19(2):169-79. PubMed ID: 8481928
    [No Abstract]   [Full Text] [Related]  

  • 13. Antisense oligonucleotides: towards clinical trials.
    Agrawal S
    Trends Biotechnol; 1996 Oct; 14(10):376-87. PubMed ID: 8987636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense anticancer oligonucleotide therapeutics.
    Wang H; Prasad G; Buolamwini JK; Zhang R
    Curr Cancer Drug Targets; 2001 Nov; 1(3):177-96. PubMed ID: 12188878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotides: a new therapeutic approach.
    Temsamani J; Guinot P
    Biotechnol Appl Biochem; 1997 Oct; 26(2):65-71. PubMed ID: 9357101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense therapeutics.
    Holt J
    Mol Med Today; 1996 May; 2(5):184-5. PubMed ID: 8796885
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene-modified cells for the treatment of cancer.
    Whartenby KA; Abraham GN; Calabresi PA; Abboud CN; Calabresi P; Marrogi A; Freeman SM
    Pharmacol Ther; 1995 Apr; 66(1):175-90. PubMed ID: 7630929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antisense oligonucleotides with pharmacologic action].
    Tauşer RG; Stoica O
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):40-5. PubMed ID: 14755968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense strategy: biological utility and prospects in the treatment of hematological malignancies.
    Warzocha K; Wotowiec D
    Leuk Lymphoma; 1997 Jan; 24(3-4):267-81. PubMed ID: 9156656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical development of antisense oligonucleotides as anti-cancer therapeutics.
    Chen HX
    Methods Mol Med; 2003; 75():621-36. PubMed ID: 12407768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.